Elevated serum TNF-α concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes

Haematologia

Volumn 29, Issue 1, 1998, Pages 13-24

  Alexandrakis, M ^a   Coulocheri, S ^a   Xylouri, I ^a   Ganotakis, E ^a   Eliakis, P ^a   Karkavitsas, N ^a   Eliopoulos, G D ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Interleukin 1 (IL 1 ); Interleukin 2 (IL 2); Interleukin 6 (IL 6); Myelodysplastic syndromes (MDS); Tumor necrosis factor (TNF )

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROME; PREDICTION AND FORECASTING; RADIOIMMUNOASSAY; SURVIVAL;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031615909     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jacobs, A.: Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J. Clin. Pathol. 38, 1201 (1985).
2. Brown, G., Bunce, C. M., Rose, P. E., Howie, A. J.: Progenitor cells and classification of myelodysplastic and myeloproliferative disorders. Lancet ii, 885 (1985) (Letter).
3. Raskind, W., Tirumali, N., Jacobson, R., Singer, J., Fialkow, P.: Evidence for a multistep pathogenesis of myelodysplastic syndrome. Blood 63, 1318 (1984).
4. Nowell, P.: Cytogenetics of preleukaemia. Cancer Genet. Cytogenet. 5, 265 (1982).
5. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Gallon, D. A., Granlick, H. R., Sultan, C.: Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51, 189 (1982).
6. Hamblin, T. J.: Myelodysplasia. Br. J. Hosp. Med. 38, 558 (1987).
7. Zoumbos, N., Symeonidis, A., Kourakli, A., Katevas, P., Matsouka, P., Peraki, M., Georgoulias, V.: Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes. Blood 77, 413 (1991).
8. Herold, M., Schmalzl, F., Zwierzina, H.: Increased serum interleukin-6 levels in patients with myelodysplastic syndromes. Leuk. Res. 16, 585 (1992).
9. Verhoef, G. E., De Schouwer, P., Ceuppens, J. L., van Damme, J., Goossens, W., Bogaerts, M. A.: Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6, 1268 (1992).
10. Ogata, K., Yokose, N., Ito, T., An, E., Dan, K., Nomura, T.: Effects of interleukin-2 on myelodysplastic syndromes. Leuk. Res. 17, 137 (1993).
11. Musto, P., Matera, R., Minervini, M., Checchia-de Abrosio, C., Bodenizza, C., Falcone, A., Carotenuto, M.: Low serum levels of tumor necrosis factor and interleukin-1β in myelodysplastic syndromes responsive to recombinant eryhropoietin. Haematologica 79, 265 (1994).
12. Seipelt, G., Ganser, A., Duranceyk, H., Maurer, A., Ottmann, O. G., Hoelzer, D.: Induction of TNF-α in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. Br. J. Haematol. 84, 749 (1993).
13. Katrinakis, G., Kyriakou, D., Papadaki, H., Kalokyri, I., Markidou, F., Eliopoulos, G. D.: Defective natural killer-cell activity in B-cell chronic lymphocytic leukemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-α. Acta Haematol. 96, 16 (1996).
14. Kishimoto, T.: The biology of interleukin-6. Blood 74, 1 (1989).
15. Rieckmann, P., D'Alessandro, F., Nordan, R. P., Fauci, A. S., Kehrl, J.: IL-6 and tumor necrosis factor-α. Autocrine and paracrine cytokines involved in B cell function. J. Immunol. 146, 3462 (1991).
16. Oster, W., Cicco, N. A., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., Mertelsmann, R. H., Herman, F.: Participation of the monokines IL-6, TNF-α, and IL-1β secreted by acute myelogenous leukemia cells in autocrine and paracrine leukemic growth control. J. Clin. Invest. 84, 451 (1989).
17. Weltzer, M., Kurzrock, R., Estrov, Z., Estev, E., Talpaz, M.: Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk. Res. 19, 23 (1995).
18. Visani, G., Zauli, G., Tosi, P., Fogli, M., Cenacchi, A., Finelli, C., Gamberi, B., Ottaviani, E., Manfoi, S., Tura, S.: Impairment of GM-CSF production in myelodysplastic syndromes. Br. J. Haematol. 84, 227 (1993).
19. Koike, M., Ishiyama, T., Tomoyasu, S., Tsuruoka, N.: Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. Leuk. Res. 19, 639 (1995).
20. Maurer, A. B., Ganser, A., Buhl, R., Seipelt, G., Ottmann, O. G., Mentzel, U., Geissler, R. G., Hoelzer, D.: Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. Leukemia 7, 1728 (1993).
21. Lindemann, A., Ludwig, W. D., Oster, W., Mertelsmann, R., Hermann, F.: High-level secretion of tumor necrosis factor-α contributes to hemopoietic failure in hairy cell leukemia. Blood 73, 880 (1989).
22. Mufti, G. J., Stevens, J. R., Oscier, D. G., Hamblin, T. J., Machin, D.: Myelodysplastic syndromes: a scoring system with prognostic significance. Br. J. Haematol. 59, 425 (1985).